The "gradual decline" group (approximately 40-50% of users) represents modal experience where benefits slowly regress toward pre-treatment baseline over 4-8 months, typically affecting users who completed shorter treatment courses (2-4 months), used lower concentrations or inconsistent application, possessed moderate to severe baseline skin damage requiring ongoing support, maintained adequate but not optimal complementary skincare, experienced significant lifestyle stressors affecting skin health including poor sleep or high stress, and faced genetic or age-related collagen production limitations
Adjust based on your specific protocol needs, syringe size, and comfort with injection volumes
Daytime sedation, impaired alertness, mood changes, allergic reactions, injection-site problems, and unexpected reactions all deserve caution
What is KLOW used for in research